Top Stock Movers Nov 18, 2026: Why SVRE, AKAN, SKYA Surged
The biggest stock gainers at the Nov 18, 2026 close: SVRE, AKAN, SKYA, CUE and VWAV. What moved them, and the risks of chasing micro-cap spikes.
SVRE — SaverOne 2014 Ltd. (+110.4%)
SaverOne surged 110.4% to close at $0.86. About 109.3 million shares traded, roughly 20 times its 20-day average of 5.6 million. The stock opened with a gap (a jump from the prior close to the open) of +97.4%. Market cap is only $3.8M.
No news, filing or announcement explains the move. Quiver Quantitative described it as traders chasing a thinly traded micro-cap with no obvious fresh catalyst. The latest SEC filing was a routine 6-K from October 26. Reddit chatter was minimal: one mention on r/pennystocks. We covered the stock earlier in our premarket recap.
The technical picture is weak despite the spike. The moving-average stack is bearish, RSI is 47, ADX is 20, and the stock is still 86.3% below its 52-week high. Conviction is 40/100 (grade D). Short-volume was 58% of the day's volume. That is not the same as short interest, but it shows heavy short-side activity. This looks momentum-driven, and such moves often reverse quickly.
AKAN — AKANDA CORP. (+95.6%)
Akanda closed up 95.6% at $4.01 on 135.8 million shares, against a 20-day average of 17.6 million. It gapped up 17.1% and has a market cap of $9.9M.
No single company announcement explains the move. Coverage describes a tiny-float name traded heavily on momentum. Kalkine noted a 62% jump the day before, and ChartMill listed AKAN among the unusual-volume leaders. The latest filings were F-1/A amendments (IPO-related) from October and November. AKAN has been in our recaps repeatedly, including Nov 16 and Nov 17's after-hours.
Technically, RSI is 81, which is overbought. ADX is 34, the moving-average stack is mixed, and the stock is still 94.9% below its 52-wk high. Conviction is only 4/100 (grade D). Free float is 90.7%, and short-volume was 57%. Reddit mentions rose to 3 from 1 a day earlier. Stocks this extended can drop as fast as they rose.
SKYA — SkyAI, Inc. (+90.3%)
SkyAI closed up 90.3% at $4.13 from a $2.17 prior close, on 9.3 million shares versus a 20-day average of 1.45 million. Market cap is $109.8M.
The likely catalyst is the final result of SkyAI's $3.00 cash tender offer, released at 4:05 PM ET on November 17. The company accepted about $210.0 million of common stock and warrants, about 92.9% of common shares outstanding. Sources do not explicitly say why the stock rose on November 18, so the link is an inference from timing. The tender left roughly 3.6 million common shares outstanding, which may have affected trading. No reverse split or new offering was found. Background: SkyAI rejected an unsolicited all-stock offer from Forward Industries before launching the tender in October. No company announcement dated November 18 was found.
Free float is just 5.1%. A low float means few shares are available to trade, so price can swing sharply on modest demand. Short-volume was 60%. The stock closed at a 52-week high, with RSI 75 and ADX 51 showing a strong trend. Conviction is 4/100 (grade D). The smart-money score is 25/100, with one 13D/G stake (largest 9.9%). An insider, Bastion Trading Ltd, bought 44,000 shares ($78K) on October 7.
CUE — Cue Biopharma, Inc. (+67.1%)
Cue Biopharma rose 67.1% to $4.73 on 11.1 million shares, about 12 times its 20-day average of 898K. It gapped up 21.2%. Market cap is $24.3M.
This looks like a bounce after a collapse. Quiver reported the stock down 70% the prior day, following a November 16 earnings 8-K and 10-Q that included a quarterly loss. B. Riley reiterated its rating but lowered its price target to $25 on financing concerns. No news explains the rebound itself, so it looks technical: a sharp oversold bounce. The 52-week high is still 89.6% above the current price.
RSI is 25, which is deeply oversold, even after the gain. ADX is 21, RS rating is 17, and conviction is 45/100 (grade D). Free float is 97.2% and short-volume was 77%, which suggests short covering may have played a part. The smart-money score is 28/100, with one 13D/G stake (10.0%). Financing concerns remain a real risk.
VWAV — VisionWave Holdings, Inc. (+57.2%)
VisionWave closed up 57.2% at $0.78 on 41.4 million shares, versus a 20-day average of 4.0 million. Market cap is $14.3M.
The likely catalyst is a November 18 press release announcing three international commercial arrangements to expand distribution in Europe and Asia. These include a memorandum of understanding with A.R.I.S. S.r.l. and a cooperation framework tied to defense markets. The release says ARIS cannot bind VisionWave or commit pricing or delivery terms, and it gives no deal values, so committed revenue is unclear. The release alone does not explain a move this size. One quote check showed a smaller intraday gain, so treat the figures with caution. No 8-K, reverse split or offering tied to the date was found, but corporate actions could still distort the price. The stock was near $2.61 in late October and near $0.50 by November 17.
Technically, a three outside up candle appeared, a bullish reversal signal. Still, RSI is 27, ADX is 45, the stack is bearish, RS rating is 1, and the stock is 99.8% below its 52-week high. Conviction is 36/100 (grade D). Free float is 36.9% and short-volume was 25%.
The bottom line
All five names are tiny, volatile and mostly D-grade. Several moved with no clear catalyst, and big one-day gainers often give back much of the move. Chasing them is high-risk. Patterns and squeezes fail, so manage risk and do your own research. This is educational, not advice. StockSetups scans the full US universe after every close and every premarket morning. See also the Nov 17 close recap.
Frequently asked questions
Why is SKYA up today?
SkyAI closed up 90.3% at $4.13. The likely catalyst is the final results of its $3.00 tender offer, released after the Nov 17 close. That link is an inference from timing, and the tender left only about 3.6 million common shares outstanding.
Why is SVRE up today?
SaverOne surged 110.4% to $0.86 with no news, filing or announcement behind it. Coverage described traders chasing a thinly traded micro-cap.
What is a low-float stock?
A low-float stock has few shares available to trade. Small amounts of buying can move the price sharply, and the price can fall just as quickly.
Why did Cue Biopharma bounce?
CUE rose 67.1% after falling about 70% the prior day on earnings. No news explains the rebound, which looks like an oversold bounce, and B. Riley flagged financing concerns.
Are these stocks buy recommendations?
No. This recap is educational only. Big one-day gainers often reverse, so do your own research and manage risk.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy